Terms: = Leukemia AND MYOD1, ENSG00000129152, 4654, P15172, PUM, MYOD, MYF3 AND Treatment
2 results:
1. Discontinuation of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia (EURO-SKI): a prespecified interim analysis of a prospective, multicentre, non-randomised, trial.
Saussele S; Richter J; Guilhot J; Gruber FX; Hjorth-Hansen H; Almeida A; Janssen JJWM; Mayer J; Koskenvesa P; Panayiotidis P; Olsson-Strömberg U; Martinez-Lopez J; Rousselot P; Vestergaard H; Ehrencrona H; Kairisto V; Machová Poláková K; Müller MC; Mustjoki S; Berger MG; Fabarius A; Hofmann WK; Hochhaus A; Pfirrmann M; Mahon FX;
Lancet Oncol; 2018 Jun; 19(6):747-757. PubMed ID: 29735299
[TBL] [Abstract] [Full Text] [Related]
2. Methylation profiling in acute myeloid leukemia.
Toyota M; Kopecky KJ; Toyota MO; Jair KW; Willman CL; Issa JP
Blood; 2001 May; 97(9):2823-9. PubMed ID: 11313277
[TBL] [Abstract] [Full Text] [Related]
